W.L.Gore & Associates is the lead sponsor of 26 current clinical trials in our USA, UK and Ireland registers. 13 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Aortic Aneurysm, Thoracic.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
NCT05811364 · Aortoiliac Occlusive Disease, Peripheral Arterial Disease
|
Not applicable | Recruiting | 2023-10 | UK, USA |
|
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
NCT06218875 · ClinicalTrials.gov ↗ · AAA - Abdominal Aortic Aneurysm
|
Observational | Recruiting | 2024-05 | UK, USA |
|
GORE® ENFORM Biomaterial Product Study
NCT04718168 · Hernia, Ventral, Hernia, Hiatal, Hernia, Diaphragmatic
|
Not applicable | Recruiting | 2021-05 | USA |
|
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
NCT07166133 · Aortic Arch Dissection, Aortic Arch Aneurysm
|
Not applicable | Recruiting | 2026-03 | USA |
|
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
NCT06658730 · ClinicalTrials.gov ↗ · Vascular Disease, Dissection, Dissection Aortic Aneurysm
|
Observational | Recruiting | 2025-06 | UK, USA |
|
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
NCT06872905 · ClinicalTrials.gov ↗ · Aortoiliac Occlusive Disease
|
Observational | Recruiting | 2025-05 | UK, USA |
|
Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access
NCT05846581 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, End Stage Renal Disease on Dialysis
|
Observational | Recruiting | 2024-01 | UK |
|
MBA Early Feasibility Study
NCT07564375 · ClinicalTrials.gov ↗ · Thoracic Aortic Aneurysm, Penetrating Aortic Ulcers (PAUs), Thoracic Aortic Dissection
|
Not applicable | Recruiting | 2026-09 | USA |
|
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
NCT04671771 · ClinicalTrials.gov ↗ · End Stage Renal Disease (ESRD), Kidney Failure, Chronic Renal Disease
|
Not applicable | Recruiting | 2020-12 | USA |
|
VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)
NCT07390344 · ClinicalTrials.gov ↗ · Ascites, Variceal Bleeding, Portal Hypertension Related to Cirrhosis
|
Observational | Recruiting | 2026-07 | USA |
|
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
NCT06827990 · ClinicalTrials.gov ↗ · Aortic Dissection
|
Not applicable | Recruiting | 2025-09 | USA |
|
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
NCT06556654 · ClinicalTrials.gov ↗ · Breast Reconstruction Surgery
|
Not applicable | Recruiting | 2025-04 | USA |
|
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
NCT03821129 · ClinicalTrials.gov ↗ · Stroke, PFO - Patent Foramen Ovale
|
Not applicable | Recruiting | 2019-07 | USA |
|
Evaluation of the GORE® Ascending Stent Graft
NCT05800743 · ClinicalTrials.gov ↗ · Aortic Aneurysm, Thoracic, Pseudoaneurysm, Aortic Dissection
|
Not applicable | By invitation | 2023-11 | USA |
|
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
NCT03728985 · Thoracoabdominal Aortic Aneurysm
|
Not applicable | Active, closed | 2019-06 | UK, USA |
|
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
NCT03441971 · Heart Defects, Congenital, Tetralogy of Fallot, Pulmonary Valve Insufficiency
|
Not applicable | Active, closed | 2018-06 | USA |
|
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT05409976 · ClinicalTrials.gov ↗ · Venous Thromboses, Venous Disease, Venous Leg Ulcer
|
Not applicable | Active, closed | 2022-10 | Ireland, UK, USA |
|
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
NCT05094089 · Hernia, Ventral, Hernia Incisional, Hernia Incisional Ventral
|
Observational | Active, closed | 2023-02 | UK, USA |
|
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
NCT06507865 · ClinicalTrials.gov ↗ · Aneurysm, Dissection, Aortic, TAA Thoracoabdominal Aortic Aneurysm
|
Observational | Active, closed | 2025-02 | UK |
|
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
NCT05489588 · Venous Thromboses, Venous Disease, Venous Leg Ulcer
|
Not applicable | Active, closed | 2023-03 | USA |
|
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry
NCT04907240 · ClinicalTrials.gov ↗ · Peripheral Artery Disease, Popliteal Aneurysm, Hemodialysis Access
|
Observational | Active, closed | 2021-10 | UK |
|
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
NCT06578741 · ClinicalTrials.gov ↗ · Abdominal Aortic Aneurysm, Pararenal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm
|
Not applicable | Active, closed | 2024-11 | USA |
|
Global Registry for Endovascular Aortic Treatment (GREAT)
NCT01658787 · ClinicalTrials.gov ↗ · Multiple Pathologies
|
Observational | Active, closed | 2010-12 | USA |
|
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
NCT02777593 · ClinicalTrials.gov ↗ · Aortic Aneurysm, Thoracic, Aorta; Lesion
|
Not applicable | Active, closed | 2016-09 | USA |
|
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
NCT02777528 · ClinicalTrials.gov ↗ · Aortic Aneurysm, Thoracic, Aorta, Lesion
|
Not applicable | Active, closed | 2016-08 | USA |
|
Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
NCT02489539 · ClinicalTrials.gov ↗ · Aortic Aneurysm, Abdominal
|
Not applicable | Active, closed | 2017-12 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 23 | 12 |
| Clinical trials in UK | 10 | 5 |
| Clinical trials in Ireland | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Bolton Medical | 1 |
Sponsors with the most current trials registered for this condition.
W.L.Gore & Associates is the lead sponsor of 26 current trials on ClinicalTrials.gov in our USA, UK and Ireland registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 13 of its 26 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.